Articles Published in 2011

Crane joins SNBL USA

Monday, November 7, 2011 10:47 AM
SNBL USA has named Mark T. Crane vice president of business development. Crane will have overall responsibility for the company’s marketing, sales and business development efforts and will be tasked with driving the growth of SNBL USA's business model and fostering positive relationships with new and current customers.

More... »


RBCC opens biotechnology headquarters in Houston

Monday, November 7, 2011 10:30 AM

Rainbow Coral (RBCC) has established the headquarters of its new biotechnology division, Rainbow BioSciences, in Houston, Texas.

More... »


ICON named clinical research team of the year

Monday, November 7, 2011 10:10 AM

ICON has won the clinical research team of the year award at the annual 2011 Scrip Awards.

More... »

NanoString raises $20 million in Series D financing

Monday, November 7, 2011 09:52 AM

NanoString Technologies, a privately held provider of life science tools for translational research and developer of molecular diagnostics, has closed $20 million in a Series D round of equity financing. New investors include GE, BioMed Ventures and Henri Termeer, former chairman and CEO of Genzyme. All previous venture investors in NanoString also participated in the financing, including Clarus Ventures, Draper Fisher Jurvetson and OVP Venture Partners.

More... »

FDA approves XARELTOR

Monday, November 7, 2011 09:34 AM

The FDA has approved XARELTOR to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. XARELTOR is the only oral anticoagulant approved in the U.S. that offers once-daily dosing, without
the need for routine blood monitoring.

More... »

CRO top executives in a game of ‘musical chairs’

Monday, November 7, 2011 08:02 AM

Five months after INC Research’s acquisition of Kendle International closed, executives from the now-combined CRO are landing jobs with competitors.  

More... »

Quintiles fills in service offerings with acquisitions

Monday, November 7, 2011 08:00 AM

Quintiles has been on an acquisitions spree. 

More... »

Scientists identify potential cancer drug development target

Friday, November 4, 2011 12:06 PM
Research led by St. Jude Children's Research Hospital scientists has identified an unexpected mechanism facilitating some protein interactions that are the
workhorses of cells and, in the process, identified a potential new cancer
drug development target.

More... »

Scrip names PPD best CRO

Friday, November 4, 2011 11:43 AM
PPD has been named the best contract research organization by Scrip Intelligence, which also has honored PPD for deploying the best technological development in clinical trials.

More... »

Jennerex enrolls first patient in phase IIb liver cancer trial

Friday, November 4, 2011 11:33 AM
Jennerex has initiated enrollment and the first patient has
been randomized in a phase IIb clinical trial called TRAVERSE.  The trial
is evaluating the use of JX-594 to treat patients with advanced liver
cancer, also known as hepatocellular carcinoma (HCC), who failed prior
therapy with sorafenib (NexavarR), the only approved drug for advanced
HCC.  In addition, Jennerex earned a milestone payment from its
development and commercialization partner, Transgene, based on the
randomization of the first patient in the TRAVERSE clinical trial.

More... »

`

CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.